Express Scripts' 2016 Formulary Continues Exclusion Of Gilead’s Harvoni
This article was originally published in The Pink Sheet Daily
Executive Summary
The pharmacy benefit manager released its national preferred formulary for 2016. AbbVie’s Viekira Pak remains the preferred alternative for hepatitis C, while Harvoni remains blocked from coverage.
You may also be interested in...
Large Employer Drug Contracting Block Could Challenge Manufacturers, PBMs
Express Scripts has been talking to members of the Health Transformation Alliance about negotiating pricing on behalf of the group, which includes 20 large employers providing health benefits for four million individuals.
Large Employer Drug Contracting Block Could Challenge Manufacturers, PBMs
Express Scripts has been talking to members of the Health Transformation Alliance about negotiating pricing on behalf of the group, which includes 20 large employers providing health benefits for four million individuals.
Lilly Prices Trulicity Near Victoza, But Well Above Tanzeum
Easy-to-use pen with invisible needle to deliver Lilly’s GLP-1 agonist dulaglutide is an asset compared to delivery of other once-weeklies in the class, but the crowded market is still very challenging.